AA
ASML icon

Altrafin AG’s ASML ASML Stock Holding History

Altrafin AG’s Portfolio ASML Stock Details ASML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-588
Closed -$777K – 45
2026
Q1 		$777K Sell
588
-975
-62% -$1.34M 0.27% 38
2025
Q4 		$1.67M Buy
1,563
+469
+43% +$489K 0.53% 30
2025
Q3 		$1.06M Buy
1,094
+412
+60% +$324K 0.34% 34
2025
Q2 		$546K Buy
682
+2
+0.3% +$1.44K 0.18% 40
2025
Q1 		$451K Buy
+680
New +$495K 0.18% 40

Other funds holding ASML

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Altrafin AG's ASML Position: Q2 2026 in Review

Altrafin AG sold out of ASML (ASML) in Q2 2026, closing a stake of 588 shares — an estimated $777K sold.

Altrafin AG first reported a position in ASML in Q1 2025 and held it in 5 quarters. The position peaked at $1.67M in Q4 2025. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Altrafin AG reported no remaining ASML position as of Q2 2026 after selling out during the quarter.
  • Altrafin AG sold 588 ASML shares in Q2 2026, an estimated $777K.
  • Altrafin AG first reported a position in ASML in Q1 2025 and held it in 5 quarters.
  • Altrafin AG's ASML position peaked at $1.67M in Q4 2025.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.